491 related articles for article (PubMed ID: 10648884)
1. Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: modulation by nitric oxide.
Lee SA; Park JK; Kang EK; Bae HR; Bae KW; Park HT
Brain Res Mol Brain Res; 2000 Jan; 75(1):16-24. PubMed ID: 10648884
[TBL] [Abstract][Full Text] [Related]
2. Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells.
Igarashi M; Yamaguchi H; Hirata A; Daimon M; Tominaga M; Kato T
Eur J Clin Invest; 2000 Aug; 30(8):668-77. PubMed ID: 10964158
[TBL] [Abstract][Full Text] [Related]
3. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes.
Chen W; Bowden GT
Oncogene; 1999 Dec; 18(52):7469-76. PubMed ID: 10602506
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2.
Hodge C; Liao J; Stofega M; Guan K; Carter-Su C; Schwartz J
J Biol Chem; 1998 Nov; 273(47):31327-36. PubMed ID: 9813041
[TBL] [Abstract][Full Text] [Related]
5. ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status.
Kim SJ; Ju JW; Oh CD; Yoon YM; Song WK; Kim JH; Yoo YJ; Bang OS; Kang SS; Chun JS
J Biol Chem; 2002 Jan; 277(2):1332-9. PubMed ID: 11689560
[TBL] [Abstract][Full Text] [Related]
6. Activation of arachidonate release and cytosolic phospholipase A2 via extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in macrophages stimulated by bacteria or zymosan.
Hiller G; Sundler R
Cell Signal; 1999 Dec; 11(12):863-9. PubMed ID: 10659994
[TBL] [Abstract][Full Text] [Related]
7. Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
Touyz RM; He G; El Mabrouk M; Diep Q; Mardigyan V; Schiffrin EL
J Hypertens; 2001 Mar; 19(3 Pt 2):553-9. PubMed ID: 11327629
[TBL] [Abstract][Full Text] [Related]
8. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway.
Ludwig S; Hoffmeyer A; Goebeler M; Kilian K; Häfner H; Neufeld B; Han J; Rapp UR
J Biol Chem; 1998 Jan; 273(4):1917-22. PubMed ID: 9442025
[TBL] [Abstract][Full Text] [Related]
9. Anisomycin uses multiple mechanisms to stimulate mitogen-activated protein kinases and gene expression and to inhibit neuronal differentiation in PC12 phaeochromocytoma cells.
Törocsik B; Szeberényi J
Eur J Neurosci; 2000 Feb; 12(2):527-32. PubMed ID: 10712794
[TBL] [Abstract][Full Text] [Related]
10. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes.
LaPointe MC; Isenović E
Hypertension; 1999 Jan; 33(1 Pt 2):276-82. PubMed ID: 9931117
[TBL] [Abstract][Full Text] [Related]
12. Low concentrations of nitric oxide (NO) induced cell death in PC12 cells through activation of p38 mitogen-activated protein kinase (p38 MAPK) but not via extracellular signal-regulated kinases (ERK1/2) or c-Jun N-terminal protein kinase (JNK).
Yamamoto T; Yuyama K; Yamamoto H
Neurosci Lett; 2006 Jan; 392(3):170-3. PubMed ID: 16198052
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
Matthews JS; O'Neill LA
Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase.
Markou T; Lazou A
Biochem J; 2002 Aug; 365(Pt 3):757-63. PubMed ID: 11994045
[TBL] [Abstract][Full Text] [Related]
15. Peroxynitrite modulates the activation of p38 and extracellular regulated kinases in PC12 cells.
Jope RS; Zhang L; Song L
Arch Biochem Biophys; 2000 Apr; 376(2):365-70. PubMed ID: 10775424
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinases confers cadmium-induced HSP70 expression in 9L rat brain tumor cells.
Hung JJ; Cheng TJ; Lai YK; Chang MD
J Biol Chem; 1998 Nov; 273(48):31924-31. PubMed ID: 9822662
[TBL] [Abstract][Full Text] [Related]
17. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase.
Tokuda H; Kozawa O; Uematsu T
J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202
[TBL] [Abstract][Full Text] [Related]
18. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.
Bhat NR; Zhang P; Lee JC; Hogan EL
J Neurosci; 1998 Mar; 18(5):1633-41. PubMed ID: 9464988
[TBL] [Abstract][Full Text] [Related]
19. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
20. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
